Study maps stem cell signals for enamel repair

Researchers at the University of Washington identified the signals that help stem cells become enamel-producing cells, a step that could support future biological tooth repair. The preclinical work, published March 2, 2026, shows that activating Notch signaling can drive human stem-cell-derived ameloblast maturation and produce enamel-like tissue in mice.

Why it matters: - Tooth enamel does not regenerate naturally after damage, so dentists currently rely on synthetic repairs such as fillings, crowns and veneers. - The study points to a possible path toward biological enamel repair, which could eventually help treat tooth damage and inherited enamel disorders such as amelogenesis imperfecta. - The work also gives researchers a human organoid system for studying tooth development and testing regenerative approaches.

What happened: - Researchers from the University of Washington studied how stem cells become ameloblasts, the specialized cells that produce enamel. - The study was published online in the International Journal of Oral Science on March 2, 2026. - The team focused on Notch signaling and the transcription factor DLX3. - Dr. Hannele Ruohola-Baker said the group wanted to test whether Notch-mediated communication from odontoblasts promotes ameloblast maturation and whether artificial activation could remove the need for odontoblast co-culture.

The details: - The researchers analyzed single-cell RNA sequencing data from developing human and mouse teeth to identify signaling pathways involved in enamel formation. - The analysis pointed to Notch as a likely communication pathway between odontoblasts and ameloblasts. - Human induced pluripotent stem cells were differentiated into tooth-related cell types and grown in co-culture or as three-dimensional ameloblast organoids. - The team blocked Notch signaling with DAPT and activated it with an engineered DLL4-based protein scaffold called C3-DLL4. - Researchers also created DLX3-deficient cell lines with CRISPR-Cas9 and assessed maturation through gene expression studies, protein analysis and mouse transplantation experiments. - Blocking Notch reduced key ameloblast maturation markers, including ENAM, AMELX and MMP20. - Activating Notch with C3-DLL4 increased those markers and allowed stem cell-derived ameloblasts to mature without odontoblast support. - The treated organoids showed mature cell features, including proper epithelial polarity and higher levels of ODAM, KLK4, TUFT1, FAM83H and WDR72. - When transplanted beneath the kidney capsule of immunodeficient mice, the organoids produced enamel-like mineralized material. - DLX3-deficient cells formed early ameloblasts and established polarity, but they did not turn on the full enamel-secreting gene program even under strong Notch stimulation. - Dr. Anjali P. Patni said key genes for enamel matrix formation and mineralization were suppressed, showing that DLX3 acts cell-autonomously to enable terminal differentiation and enamel protein production. - The study is titled "Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration." - The paper DOI is https://doi.org/10.1038/s41368-026-00429-4. - The work was supported by the ISCRM Fellows Program and multiple grants from the National Institutes of Health, NHLBI, SCGE, the AHA, Brotman Baty Institute, DOD and Stem Cell Gift Funds.

Between the lines: - The findings suggest that enamel formation can be guided in the lab by replacing natural odontoblast signals with an engineered Notch activator. - The study also narrows the field by showing that Notch is important for maturation, but DLX3 is still required for the final enamel-producing program. - That combination matters because regenerative dentistry will need both cell signaling control and terminal differentiation control to make usable tissue.

What's next: - The work remains preclinical, so human therapy is not close yet. - The C3-DLL4 scaffold could be refined to better mimic natural developmental signals. - The organoid platform could be used for disease modeling, drug screening and personalized therapy research. - Future studies will need to test whether the approach can be made safe, scalable and durable for clinical dental repair.

The bottom line: - The University of Washington study identifies Notch signaling as a central driver of human ameloblast maturation and shows that engineered pathway activation can produce enamel-like tissue from stem cells.